The growth of this market is majorly driven by the technological advancements in stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population. However, the presence of alternative treatment methods for vascular diseases, stringent regulations for product approval, and numerous cases of product failure and product recalls are expected to restrain the growth of the vascular stents market during the forecast period of 2016 to 2021.
The global Vascular Stent Market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% during the forecast period. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=199869009 This report segments the vascular stents market based on product, type, mode of delivery, material, end user, and region. Based on type, the market is segmented into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The drug-eluting stents segment is expected to account for the largest share of the vascular stents market in 2016. This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications. Based on the mode of delivery, the vascular stents market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents segment is expected to grow at the highest CAGR during the forecast period primarily due to the growing regulatory approvals for balloon-expandable stents and the high usage of these stents in angioplasty procedures. Based on region, the vascular stents market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America was the largest market for vascular stents in 2016. However, the Asian market is projected to register the highest growth during the forecast period. Speak To Analyst:-https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=199869009 The key players operating in this market include Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).
0 Comments
E-commerce platform allows organizations to offer goods and services digitally. This platform handles back-end processes such as billing, order processing, product control, and customer support. With an integrated e-commerce platform, all these functions can be handled from a unified interface, and switching between the apps gets eliminated. This, in return, enhance employee productivity and allows organizations to serve customers better.
360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions. Quadrants are generated post analysis of companies (product portfolios and business strategy) and will be updated every three months based on market and regional analyses and developments in E-Commerce Platforms space. 360Quadrants conducts an in-depth SWOT analysis and accurately analyses the companies considered for evaluation. This helps service providers in learning about new opportunities and areas where they lag behind their peers. It also helps clients in choosing the most appropriate vendor for their specific requirements. Know More: - https://www.360quadrants.com/software/e-commerce-platforms E-commerce Platforms Competitive Landscape 360Quadrants evaluated over 40 companies in the E-Commerce Platforms space, out of which, 19 companies are categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. Shopify, WooCommerce, BigCommerce, and Ecwid have been recognized as visionary leaders as they have established product offerings, and they focus on further strengthening their market position. Shopmatic, Zepo, Zoey, Ecomchain, and Storm have been considered as innovators. These companies focus on product innovations and invest heavily in R&D to expand their product portfolios. Digital River, Handshake, Kartrocket, and Teespring have been listed as emerging companies. These players provide a unique range of products but have a limited market approach. 2Checkout, Paypro Global, Square E-Commerce, nopCommerce, Sellfy, and Prestashop have been identified as dynamic differentiators. These companies rely mostly on their innovative research and development infrastructure. The report analyzes and studies the major drivers, restraints, opportunities, and challenges of the CT scanners market in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Factors like growing need for effective and early diagnosis, rising global prevalence of targeted, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans, and technological advancements are driving the growth of the market.
The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184364345 On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets. Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners. Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=184364345 The major players in the CT scanner market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea). Report explores the Research Antibodies Market is expected to reach $ 12.60 Billion by 20228/27/2020 Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market.
The Research Antibodies Market is expected to reach USD 12.60 Billion by 2022 from an estimated USD 9.33 Billion in 2017, at a CAGR of 6.2% during the forecast period. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 Based on technology, the western blotting segment accounted for the largest share of the research antibodies market. Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth. On the basis of product, the reagents segment accounted for the largest share of the global research antibodies market (including reagents), in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques. Based on application, the proteomics segment accounted for the largest share of the research antibodies market. The large share of this segment is attributed to the deployment of proteomic-based approaches in biomarker detection and cancer profiling, increasing R&D expenditure, and availability of funds from various organizations. Based on end user, the pharmaceutical & biotechnological companies segment accounted for the largest share of the research antibodies market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector. North America accounted for the largest share of the research antibodies market in 2016, followed by Europe. Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793 The major players in the research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (U.S.), Merck Group , Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.). The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market.
The Blood Screening Market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Based on product & service, the blood screening market is segmented into reagents and kits, instruments, and software and services. The reagents and kits segment accounted for the largest share of the blood screening market in 2019. The large share of this segment can be attributed to the high consumption and repeated use of reagents & kits in blood screening procedures. Also, the accessibility of a wide range of reagents and the need for reliable, specific, and fast detection of TTIs are driving the growth of the blood screening reagents & kits market. Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, an increasing number of donations worldwide, and growth in government funding to charitable trusts. Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe. Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=267747042 The prominent players operating in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India). E-commerce platforms are a tech framework that help company owners control their selling activities digitally. Several market vendors provide various platforms of ecommerce to match various business needs. Each platform has its own benefits and drawbacks, and companies choose the one that fits their needs. E-commerce platforms typically represent the front end aspect of a company and facilitates online selling of goods to the customers.
360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions. Quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the E-Commerce Platforms space. 360Quadrants conducts an in-depth SWOT analysis and accurately analyzes the companies considered for evaluation. This helps service providers in learning about new opportunities and areas where they lag behind their peers. It also helps clients in choosing the most appropriate vendor for their requirements. Know More: - https://www.360quadrants.com/software/e-commerce-platforms Categorization of E-commerce Platform Providers 360Quadrants evaluated over 35 companies in the E-Commerce Platforms space out of which 19 companies were categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. Shopify, WooCommerce, BigCommerce, and Ecwid have been identified as visionary leaders as they have established product portfolios and a robust market presence and business strategies. Shopmatic, Zepo, Zoey, Ecomchain, and Storm have been identified as innovators as they have focused product portfolios, and innovative business strategies which help them in growing consistently. Digital River, Handshake, Kartrocket, and Teespring have been identified as emerging companies as they have niche product offerings and decent business strategies. 2Checkout, Paypro Global, Square E-Commerce, nopCommerce, Sellfy, and Prestashop have been recognized as dynamic differentiators as they are largely dependent on their competitive R&D activities. The major factors driving the growth of the particle size analysis market include increasing research activities in the field of nanotechnology; technological advancements in particle size analyzers; increasing investment in pharmaceutical R&D; and stringent regulatory guidelines for product quality across industries.
The global Particle Size Analysis Market is projected to reach USD 465 million by 2025 from USD 356 million in 2020, growing at a CAGR of 5.5% during the forecast period Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 The particle size analysis market is segmented on the basis of product into segmented into laser diffraction, dynamic light scattering (DLS), imaging, nanotechnology particle analysis (NTA), the Coulter principle, and other technologies (resonant mass measurement, laser obscuration, sedimentation, and sieve analysis). The imaging technology segment is further sub segmented into dynamic and static imaging. The laser diffraction technology segment commanded the largest share of the global particle size analysis market in 2020. The large share of this segment is attributed to laser diffraction’s wide dynamic measurement range, a feature that significantly increases its application areas. Based on the type of industry, the global particle size analysis market is classified into five major segments—healthcare; chemicals and petroleum; mining, minerals, and cement; food and beverage; and other industries. The last segment comprises industries related to inks, toners, paint, coatings, cosmetics, and environmental analysis. The healthcare industry segment is expected to account for the largest share of the particle size analysis market in 2017 due to its dominance can be attributed to the increasing applications of nanotechnology in medical science, the rapid growth of pharmaceuticals in the healthcare industry. Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global particle size analysis market during the forecast period. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=74084833 The major players operating in the particle size analysis market include Malvern Instruments Limited (UK), HORIBA, Ltd. (Japan), and Beckman Coulter, Inc. (US). Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market.
The report Ventilator Market is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337 On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries. On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators. Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market. The large share of this segment can be attributed to the large patient population with severe COPD, asthma, and other chronic respiratory diseases; rising number of smokers; and rapid growth in the geriatric population.Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market.North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=11018337 The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland). Revenue Cycle Management (RCM) in healthcare industry has fast become a buzzword over the past few years. It enables the healthcare organizations to manage payments, claims processing, and revenue generation, thereby accelerating the whole revenue cycle in an efficient manner. RCM solution begins when a patient enters or schedules an appointment. It automates the whole procedure with initiation of the process by the patient, quick follow ups, determining the eligibility of the patient, collecting their payment, effective tracking of the claims process, and working on rejected claims among others.
The Revenue Cycle Management Market is expected to reach USD 160.08 billion by 2027 from USD 66.81 billion in 2019, at a CAGR of 12.1%. Regulatory mandates for the adoption of EHR/EMR and government initiatives to boost the adoption of RCM solutions are the major factors driving the adoption of RCM solutions. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153900104 On the basis of function, the market is broadly segmented into claim and denial management, medical billing and coding, patient insurance eligibility check, payment remittance, electronic health record (EHR), clinical documentation improvement (CDI), and others. The claim and denial management segment is expected to account for the largest share of the global revenue cycle management market in 2019 and is expected to witness the highest CAGR during the forecast period. The growing demand for claims and denial management due to the dynamic reimbursement structure and the increasing instances of claim denials are the major factors driving the growth of this segment. What’s driving the Market? The growth of the global revenue cycle management market is primarily propelled by the following factors:
Although this market is set to witness a healthy growth ahead, higher costs of RCM solutions and limited number of investments being made in healthcare IT sector are likely to inhibit the growth of this market over the forecast period. Request for Sample Report: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=153900104 The key players in the global revenue cycle management market are McKesson (US), Cerner (US), Quest Diagnostics (US), Allscripts Health Solutions (US), and athenahealth (US). The growth of this segment can be attributed to the advantages portable colposcopes offer, which includes ease of installation and movement within medical settings, better result reproducibility, and the ability to produce high-definition images, and stable cervix examinations.
The Colposcopy Market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210884594 The heavy burden of cervical cancer, rapidly growing geriatric population, and technological advancements in colposcopy are the key factors driving the growth of this market. The colposcopy market is segmented on the basis of instrument type into optical colposcopes and digital colposcopes. In 2018, the optical colposcope segment is expected to account for the largest share of the colposcopy market. The large share of this segment can be attributed to advantages such as easy installation and low cost of these instruments. On the basis of instrument portability, the market is segmented into portable, fixed, and handheld colposcopes. The portable colposcopes segment is expected to account for the largest share of the market in 2018 and it is also expected to grow at the highest CAGR during the forecast period. Based on region, the colposcopy market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the colposcopy market in 2018 and this trend is likely to continue during the forecast period. Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=210884594 Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany). |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |